Foghorn Therapeutics Inc Sustainability Reports
Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel medicines that target the chromatin regulatory system for the treatment of cancer and other serious diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00HFZPB97
3 reports from 2020 to 2023
Company Profile
Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel medicines that target the chromatin regulatory system for the treatment of cancer and other serious diseases.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
